Skinvisible, Inc. (SKVI): Gross Profit
$20.0K
Year ended 2025-12-31
$20.0K
Trailing 12 months to 2026-06-30
-58.2%
3-year compound annual growth
-40.8%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $20.0K | 0.0% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $20.0K | 0.0% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $20.0K | -92.7% | 2025-04-14, From 2023-01-01 |
| 2022-12-31 | $274.5K | -58.4% | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $660.1K | +139.6% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $275.6K | +975.8% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $25.6K | n/c | 2021-04-15, From 2019-01-01 |
| 2018-12-31 | $48.6K | -91.7% | 2020-05-14, From 2018-01-01 |
| 2017-12-31 | $586.7K | +716.8% | 2019-04-15, From 2017-01-01 |
| 2016-12-31 | $71.8K | -39.0% | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | $117.7K | +314.0% | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | $28.4K | -55.9% | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | $64.5K | -75.7% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $265.7K | +48.8% | 2014-04-11, From 2012-01-01 |
| 2011-12-31 | $178.5K | -14.9% | 2013-04-16, From 2011-01-01 |
| 2010-12-31 | $209.7K | n/a | 2012-11-19, From 2010-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $20.0K | 0.0% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $17.6K | n/a |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $12.5K | +210.1% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$53.0K | n/a |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$392.0K | n/a |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $10.8K | -98.9% |
| Aspire Biopharma Holdings, Inc. (ASBP) | 2025-12-31 | -$116 | n/a |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $27.8K | -58.0% |
| One World Products, Inc. (OWPC) | 2024-12-31 | $3.9K | n/m |
Compare SKVI, JUNS, BDPT, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗